Sort
15,273 grants matching “antimicrobial resistance”
Antimicrobial Dental Devices and Waterlines
$492,971Ted Reid · Selenium, Ltd · R42 · FY2010 · DE
Lung-resident antibacterial heterotypic immunity
$492,924Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2019 · AI
Inhibition of HeptosyltransferaseI for the treatment of Gram-negative bacterial infection
$492,900Erika A Taylor · Wesleyan University · R15 · FY2015 · AI
The matrix of Pseudomonas aeruginosa biofilms
$492,759Daniel J Wozniak · Wake Forest University Health Sciences · R01 · FY2007 · AI
Human macrophage variation & TB pathogenesis
$492,747Thomas R Hawn · University Of Washington · U19 · FY2021 · AI
The matrix of Pseudomonas aeruginosa biofilms
$492,692Daniel J Wozniak · Wake Forest University Health Sciences · R01 · FY2006 · AI
Broadly active inhibitors of high priority pathogens
$492,597Sequoia Pharmaceuticals, Inc. · R43 · FY2003 · AI
Network for Antimicrobial Resistance in Staphylococcus aureus
$492,582Daniel Sahm · Eurofins Medinet Inc · N01 · FY2013 · AI
Task A24: Establishment of Chronic Pseudomonas aeruginosa and Staphylococcus aureus Infection in Mouse Models of Cystic Fibrosis
$492,456Ralph Baric · Univ Of North Carolina Chapel Hill · N01 · FY2021 · AI
Implementing Diagnostic Stewardship to Reduce Antibiotic Use and Resistance in Critically Ill Children
$492,298Aaron M Milstone · Johns Hopkins University · R18 · FY2018 · HS
Novel Polymer Matrix for Dental Applications
$492,264Robert D Bolskar · Tda Research, Inc. · R44 · FY2019 · DE
Developing triazolopyrimidines as novel anti-tubercular agents
$492,250Tanya Parish · Seattle Children'S Hospital · R56 · FY2022 · AI
Topoisomerases and Chromosome Segregation
$492,124Kenneth J Marians · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
$492,120Ambrose L. Cheung · Dartmouth College · R01 · FY2012 · AI
Trehalose Pathway for Antifungal Targets and Inhibitors
$492,059Richard Gerald Brennan · Duke University · P01 · FY2019 · AI
S AUREUS PATHOGENESIS IN HIV INFECTION AND IN DRUG USE
$491,984Columbia University Health Sciences · R01 · FY2000 · DA
De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children
$491,899Jason Newland · Washington University · R01 · FY2020 · HS
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis
$491,851Richard A Bunce · Oklahoma State University Stillwater · R01 · FY2014 · AI
Molecular regulation of anti-inflammatory cytokine receptor in sepsis
$491,628Yutong Zhao · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · HL
Cell-mediated protection against pneumonic plague
$491,569Stephen T Smiley · Trudeau Institute, Inc. · R56 · FY2008 · AI
Role of the environmental sensor, AhR on colitis
$491,569Prakash S. Nagarkatti · University Of South Carolina At Columbia · R01 · FY2024 · AI
Cd1d regulation and its effect on NKT cell activation
$491,515Samuel M Behar · Brigham And Women'S Hospital · R01 · FY2008 · HL
Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum
$491,329David Armand Fidock · Columbia University Health Sciences · R01 · FY2023 · AI
Hospital-Acquired Mupirocin-Resistant MRSA in Post-Partum Women and Newborns
$491,279Sharon Beth Brodie Wright · Beth Israel Deaconess Medical Center · R18 · FY2013 · HS
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
$491,230Barbara Wells Trautner · Baylor College Of Medicine · R01 · FY2021 · HS